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H7 subtype inﬂuenza viruses have demonstrated an ocular tropism in humans, causing conjunctivitis and not
respiratory symptoms in many infected individuals. However, the molecular determinants which confer ocular
tropism are still poorly understood. Here, we used a murine model of ocular inoculation to demonstrate that H7
inﬂuenza viruses are more likely to cause infection following ocular exposure than are non-H7 subtype viruses.
We included investigation regarding the potential role of several properties of inﬂuenza viruses with murine
infectivity following ocular inoculation, including virus lineage, pathogenicity, and HA cleavage site composition. Furthermore, we examined the potential contribution of internal proteins to murine ocular infectivity.
These studies establish a link between H7 subtype viruses and the risk of heightened infectivity in a mammalian
species following ocular exposure, and support the development of non-traditional inoculation methods and
models to best understand the human risk posed by inﬂuenza viruses of all subtypes.

1. Introduction
H7 subtype inﬂuenza viruses, with the notable exception of H7N9
viruses, are typically associated with ocular complications in humans,
with ~80% of reported cases presenting with conjunctivitis (Belser
et al., 2009a). In contrast, the majority of non-H7 subtype avian and
human inﬂuenza viruses generally present with respiratory symptoms
in humans, with ocular complications only rarely reported (Belser
et al., 2013c). However, the human eye and surrounding conjunctiva
represent a secondary mucosal surface bearing permissive receptors
susceptible to virus infection (Kumlin et al., 2008), underscoring that
ocular exposure to inﬂuenza viruses represents a potential route of
virus entry for multiple virus subtypes. Thus, elucidating how inﬂuenza
viruses use the eye as a means to establish a respiratory infection, and
determining the viral and host features which govern ocular tropism,
will oﬀer critical information which can guide public health responses
during outbreaks of H7 subtype virus.
The capacity for inﬂuenza viruses to cause disease following ocular
exposure has been examined in several in vitro and in vivo models.
Multiple human ocular cell types (including corneal and conjunctival
cells) have demonstrated the ability to support productive replication
of both human and avian inﬂuenza viruses (Belser et al., 2011b; Chan
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et al., 2010; Michaelis et al., 2009). Similarly, ferrets (challenged with
either a liquid or aerosol inoculum) have revealed a capacity for both
human and avian inﬂuenza viruses to use the eye as a portal of entry to
establish a productive respiratory infection (Aamir et al., 2009; Belser
et al., 2014, 2012a). In contrast, ocular inoculation of mice has shown
that H7 inﬂuenza viruses appear to more frequently infect following
inoculation and are detected in the eye more often than other virus
subtypes (Belser et al., 2009b; Sun et al., 2009; Tannock et al., 1985).
Identifying a mammalian model which recapitulates the tropism
observed in humans oﬀers an opportunity to investigate which features
of H7 subtype viruses confer ocular tropism or ocular infectivity in
vivo. Here, we assess numerous viral properties for their inﬂuence on
murine infectivity following ocular inoculation, including the contribution of surface glycoprotein composition, HA cleavage site, lineage,
receptor binding preference, and internal gene constellation. We ﬁnd
that, in agreement with human epidemiological reports, H7 subtype
viruses are more likely to cause infection following ocular inoculation
in a mammalian model, and are more likely than other virus subtypes
to replicate within ocular tissue, including H5N1 viruses. Identiﬁcation
of properties which do or do not confer ocular tropism in a mammalian
host provides needed information to more precisely determine the
molecular correlates which govern this attribute in humans.
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Table 1
Influenza viruses tested for infectivity by the ocular route in mice.
Subtype

IVPIa

Virus name

Isolate source

# inocb

# infc

References

H7N2
H7N2
H7N3
H7N3
H7N3
H7N3
H7N7
H7N7
H7N7
H7N8
H7N8
H7N9
H7N9
H7N9
H7N9
H7N9
H7N9
H7N9
H5N1
H5N1
H5N1
H5N1
H5N1
H5N1
H3N2
H3N2
H1N1
H1N1
H1N1
H1N1
H1N1
H1N1
H1N1
H1N1

LPAI
LPAI
HPAI
LPAI
LPAI
HPAI
HPAI
HPAI
HPAI
HPAI
LPAI
LPAI
LPAI
LPAI
LPAI
LPAI
LPAI
LPAI
HPAI
HPAI
HPAI
HPAI
HPAI
HPAI
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

A/New York/107/2003
A/chicken/Connecticut/260413-2/2003
A/Canada/504/2004
A/Canada/444/2004
A/Red Knot/New Jersey/1523470/2006
A/Mexico/InDRE7218/2012
A/Netherlands/219/2003
A/Netherlands/230/2003
A/chicken/Netherlands/1/2003
A/turkey/Indiana/1403/2016
A/turkey/Indiana/1573-2/2016
A/goose/Nebraska/17096-1/2011
A/shoveler/Egypt/00215-NAMRU3/2007
A/Anhui/1/2013
A/Shanghai/1/2013
A/Taiwan/1/2013
A/Hong Kong/5942/2013
A/British Columbia/1/2015
A/Hong Kong/483/1997
A/Hong Kong/486/1997
A/Hong Kong/213/2003
A/Vietnam/1203/2004
A/Thailand/16/2004
A/Indonesia/5/2005
A/Aichi/1/1968
A/Memphis/102/1972
A/South Carolina/1/1918
A/South Carolina/1/1918-AV
A/New Jersey/8/1976
A/Ohio/2/2007
A/California/4/2009
A/California/4/2009-222G
A/Mexico/4108/2009
A/Mexico/4482/2009

Human respiratory case
avian
Human conjunctivitis case
Human conjunctivitis case
avian
Human conjunctivitis case
Human fatal case
Human conjunctivitis case
avian
avian
avian
avian
avian
Human fatal case
Human fatal case
Human respiratory case
Human respiratory case
Human respiratory case
Human fatal case
Human respiratory case
Human respiratory case
Human fatal case
Human fatal case
Human fatal case
Human respiratory case (seasonal)
Human respiratory case (seasonal)
Reconstructed 1918 pandemic virus
Reconstructed 1918 pandemic virus
Human respiratory case (seasonal)
Human respiratory case (triple reassortant swine)
Human respiratory case (2009 pandemic)
Point mutant of 2009 pandemic virus
Human respiratory case (2009 pandemic)
Human respiratory case (2009 pandemic)

6
6
21
12
6
16
20
12
6
9
10
6
6
14
6
6
6
8
12
10
6
10
12
6
6
6
6
6
6
6
6
6
6
6

0
0
16
10
1
15
20
8
2
1
0
4
3
12
5
6
6
7
9
0
0
4
9
1
1
0
3
0
0
0
0
0
0
0

(Belser et al., 2009b)
this study
(Belser et al., 2012b, 2009b)
(Belser et al., 2009b)
(Belser et al., 2013a)
(Belser et al., 2013a)
(Belser et al., 2012b, 2009b)
(Belser et al., 2009b)
(Belser et al., 2009b)
(Sun et al., 2016a)
(Sun et al., 2016a)
(Belser et al., 2013a)
(Belser et al., 2013b)
(Belser et al., 2016, 2013b)
(Belser et al., 2013b)
(Belser et al., 2016)
(Belser et al., 2016)
(Belser et al., 2016)
(Belser et al., 2009b)
(Belser et al., 2009b)
(Belser et al., 2009b)
(Belser et al., 2009b)
(Belser et al., 2009b)
this study
(Belser et al., 2009b)
(Belser et al., 2009b)
(Belser et al., 2009b)
(Belser et al., 2009b)
(Belser et al., 2010)
(Belser et al., 2010)
(Belser et al., 2011a)
(Belser et al., 2011a)
(Belser et al., 2010)
(Belser et al., 2010)

a
b
c

IVPI, intravenous pathogenicity index. HPAI, highly pathogenic avian inﬂuenza; LPAI, low pathogenic avian inﬂuenza. N/A, not applicable.
Total number of mice inoculated (inoc) by the ocular route with 106 PFU or EID50/5µl of virus.
Number of mice infected (inf) following ocular inoculation, deﬁned by detection of infectious virus in the eye, nose, or lung through day 6 post inoculation.

2. Methods

2.2. Murine ocular inoculation

2.1. Viruses

Female BALB/c mice (6-to-8 weeks of age) were inoculated by the
ocular route as previously described (Belser et al., 2009b). Infection
was determined by harvesting the eyes (pooled), nose, and lungs of
mice on days 3 and 6 post-inoculation (p.i.), followed by homogenizing,
and titrating them in eggs or cells. The limit of detection was 100.8
EID50/ml or 10 PFU/ml. Ocular pathotyping data from mice were
collected from previously published studies (indicated with a reference
in Table 1) or generated for this study (indicated as such in Table 1,
Table 3). All wild-type viruses included in the study have been shown
previously to infect mice by the intranasal inoculation route without
prior adaptation. The dataset presented in Table 1 is limited to
experiments performed at the Centers for Disease Control and
Prevention under an Institutional Animal Care and Use Committeeapproved protocol to minimize experimental variability.

Inﬂuenza A viruses included in the analyses in this study are shown
in Tables 1 and 3, with ocular pathotyping data for each virus either
published previously (as indicated by the presence of a reference in
Table 1) or generated for this study. All viruses were propagated in the
allantoic cavity of 10-day-old embryonating chicken eggs, with the
exception of pandemic 1918 and 2009 H1N1 viruses, which were
propagated in Madin-Darby canine kidney (MDCK) cells, as referenced
in Table 1. The 50% egg infectious dose (EID50) titer for each virus
stock was calculated by the method of Reed and Muench (Reed and
Muench, 1938). The PFU titer was determined by standard plaque
assay in MDCK cells (Zeng et al., 2007). All experiments with avianorigin viruses were conducted under biosafety level 3 containment,
including enhancements required by the U.S. Department of
Agriculture and the Division of Select Agents and Toxins/CDC
(Chosewood and Wilson, 2009).
Reassortant viruses were generated by transfecting the reverse
genetics plasmids encoding the HA and NA surface genes from the
virus of interest along with the six internal genes from PR8 inﬂuenza
virus into qualiﬁed Vero or 293-T cells (O'Neill and Donis, 2009;
Ridenour et al., 2015; Sun et al., 2016b). For hemagglutinin genes
derived from H5N1 highly pathogenic avian inﬂuenza virus, including
A/Vietnam/1203/2004 and A/Indonesia/5/2005, overlapping PCR
mutagenesis was performed to remove the polybasic amino acids
(O'Neill and Donis, 2009; World Health Organization Global
Inﬂuenza Program Surveillance, 2005).

2.3. Statistical analyses
Statistical analyses were performed using R version 3.2.3, including
the binom and MRCV packages (Dorai-Raj, 2014; Koziol and Bilder,
2014; The R Core Team, 2015). Because multiple hypotheses were
being tested, two-tailed p values < 0.01 are considered signiﬁcant and
99% conﬁdence intervals are given. Infection frequencies were compared using Fisher's exact or Fisher-Freeman-Halton tests. Data
comparing rates of virus detection in diﬀerent tissues between H5
and H7 viruses were tested for simultaneous pairwise marginal
independence using a modiﬁed Pearson chi-square statistic with
Bonferroni adjustment as previously described (Agresti and Liu,
14
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frequency of infection following ocular inoculation in the mouse model,
regardless of the neuraminidase with which it is paired or the lineage
from which it is derived.

1999). Hemagglutinin subtype was treated as a single-response multiple-choice variable, while the tissues in which virus was detected was
treated as a multiple-choice multiple response variable. Graphics were
generated using GraphPad Prism 6 software.

3.2. Contribution of hemagglutinin cleavage site to ocular infectivity
3. Results

Avian inﬂuenza viruses are classiﬁed as either highly pathogenic
avian inﬂuenza (HPAI) or low pathogenic avian inﬂuenza (LPAI)
viruses based on their virulence in chickens [per the Intravenous
Pathogenicity Index (IVPI) or chicken lethality tests] or similarity of
molecular attributes within the HA cleavage site motif to other HPAI
viruses (OIE, 2015). While HPAI viruses frequently present with
enhanced virulence in mammals compared with LPAI viruses, this is
not always the case; both H7 HPAI and LPAI viruses have been
associated with severe human infection and ocular disease. In mice, H7
HPAI viruses caused infection more frequently than did LPAI viruses
(74% vs 59%, respectively), but this diﬀerence was not statistically
signiﬁcant (Fig. 1D). These results aﬃrm that H7 LPAI and HPAI
viruses are both capable of causing mammalian infection by the ocular
route.
Among H7 viruses, it is not uncommon for a LPAI virus to acquire a
HPAI phenotype during the course of an outbreak in poultry; examination of both LPAI and HPAI viruses sourced from the same outbreak
thus permits an opportunity to examine speciﬁc molecular determinants of pathogenicity that may not be possible among other wild-type
viruses. To more closely investigate the role of the HA cleavage site in
ocular infectivity, we examined two pairs of viruses isolated from the
same outbreak that emerged via nonhomologous recombination events
and diﬀer primarily in their IVPI classiﬁcation and cleavage site. The
H7N3 viruses A/Canada/504/2004 and A/Canada/444/2004 share
high sequence identity and diﬀer in their HA cleavage site by one
amino acid (Hirst et al., 2004), and the H7N8 viruses A/turkey/
Indiana/1403/2016 and A/turkey/Indiana/1573-2/2016 diﬀer by only
eight amino acids and a three basic residue insertion in the HA
cleavage site (Sun et al., 2016a). As shown in Table 1, we observed
no pronounced diﬀerence in murine infectivity between either pair of
viruses (76% and 83% infectivity between H7N3 HPAI and LPAI
viruses and 11% and 0% infectivity between H7N8 HPAI and LPAI
viruses, respectively), further supporting a noncritical role for chicken
virulence classiﬁcation and cleavage site composition in mammalian
ocular infectivity (Belser et al., 2009b; Sun et al., 2016a).

3.1. Contribution of surface glycoproteins to ocular infectivity
Inﬂuenza viruses of multiple subtypes have been shown to infect
mice by the ocular route, with select H7 and H5 viruses capable of
causing a fatal infection following ocular inoculation (Belser et al.,
2009b). However, while H7 inﬂuenza viruses appear well-suited to
infect mice by this inoculation route, it was unknown if the presence of
an H7 hemagglutinin confers an enhanced ability for inﬂuenza virus to
infect mice following ocular inoculation. To ascertain if murine
infection following ocular inoculation occurred more frequently for
viruses bearing an H7 hemagglutinin than for those of other HA
subtypes, we examined a panel of 34 inﬂuenza viruses (Table 1). In this
analysis, animals were counted as “infected” if infectious virus was
detected in any tissue (eye, nose, or lung) above our limit of detection
on either day 3 or 6 p.i. We found that H7 viruses were 2.8 times as
likely to cause infection as were non-H7 viruses (p < 0.001) (Table 2,
Fig. 1A). Separating the non-H7 viruses by subtype revealed that
infection was most frequent after exposure to H5 viruses (41% of mice
infected), but still lower than for H7 viruses (66% of mice infected, p <
0.001) (Table 2, Fig. 1B).
The plasticity of the H7 hemagglutinin to accommodate numerous
neuraminidase subtypes in isolates associated with human infection is
a feature not typically observed with other hemagglutinins. While
ocular complications (with or without respiratory involvement) have
been reported following human exposure with H7N2, H7N3, and
H7N7 viruses, H7N9 viruses are typically associated with severe
respiratory and not ocular disease (Belser et al., 2009a; To et al.,
2014). To examine if the neuraminidase paired with the H7 hemagglutinin inﬂuences the capacity to cause infection following ocular
inoculation in mice, we examined the risk of murine infection following
inoculation with H7 viruses separated by NA subtype. We found that
the neuraminidase coupled with the H7 HA did not signiﬁcantly alter
virus infectivity in this model, as the three H7 HA-NA combinations
most frequently associated with human infection (H7N3, H7N7, and
H7N9) all possessed infection rates > 75% with no signiﬁcant diﬀerences observed among any of them (p=0.73, Fig. 1B; H7N2 and H7N8
were excluded from this analysis due to small sample size and lack of
diversity among tested isolates). Both Eurasian and North American
lineage H7 viruses have been associated with human infection, whereas
human infections with H5N1 viruses have been limited to those from
the Eurasian lineage. Among these three H7 HA-NA combinations, we
did not detect a signiﬁcant diﬀerence between North American (H7N3,
H7N9) and Eurasian (H7N7, H7N9) lineage viruses in the frequency of
ocular infection of mice (p=0.41, Fig. 1C). Collectively, these analyses
indicate that the presence of an H7 hemagglutinin strongly aﬀects the

3.3. Contribution of internal genes to ocular infectivity
Despite the elevated frequency of infection following ocular inoculation with H7 viruses compared with non-H7 viruses, the presence of
an H7 HA alone is not suﬃcient to confer an ocular tropism in mice or
humans (Belser et al., 2013c). As such, it is likely that internal virus
genes contribute to this property. To more speciﬁcally address this
question, we examined the infectivity of reassortant inﬂuenza viruses
possessing surface glycoproteins from wild-type inﬂuenza viruses with
all internal genes derived from A/Puerto Rico/8/1934 (PR/8), a
laboratory-adapted H1N1 virus found not to infect mice by the ocular
route (Table 3). Infectivity in mice by the ocular route was maintained
despite replacing the internal genes of the H7N9 LPAI virus A/Anhui/
1/2013, at 86% (following wild-type virus infection, Table 1) and 80%
(following PR/8 reassortant virus infection, Table 3). In support of this
ﬁnding, an additional H7N9 PR/8 reassortant virus tested, bearing
surface glycoproteins from A/Shanghai/2/2013 virus, exhibited 100%
infectivity in mice by the ocular route (Table 3). However, replacing the
internal genes of the H7N3 HPAI virus A/Mexico/InDRE7218/2012
was suﬃcient to abrogate virus infectivity by the ocular route in mice,
from 94% (following wild-type virus infection, Table 1), to 0%
(following PR/8 reassortant virus infection, Table 3). These ﬁndings
indicate that internal genes likely contribute to ocular tropism in a
strain-speciﬁc manner.

Table 2
Frequency of infection following murine ocular inoculation by virus subtype.
Virus
subtypea

# of
viruses

# infected
mice

# mice
inoculated

% Infected

Risk
ratiob

p-valuec

H7
Non-H7
H1
H3
H5

18
16
8
2
6

116
27
3
1
23

176
116
48
12
56

66%
23%
6%
8%
41%

–
2.8
10.5
7.9
1.6

–
2E−17
3E−19
2E−04
4E−05

a
b
c

Non-H7, inclusive of all viruses listed in Table 1.
Risk ratio for H7, using the indicated subtype as a reference.
p-value determined by Fisher's exact test .
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Fig. 1. Risk of murine infection following ocular inoculation with inﬂuenza virus. Mice were inoculated by the ocular route with inﬂuenza viruses shown in Table 1 and separated into
“infected” or “not infected” groups based on detection of infectious virus in the eye, nose, or lung through day 6 p.i. (limit of virus detection, 100.8 EID50/ml or 10 PFU/ml). Error bars
represent 99% conﬁdence intervals. A, risk of murine infection between all inﬂuenza viruses listed in Table 1 bearing an H7 hemagglutinin (18 viruses) and viruses bearing a non-H7
hemagglutinin (16 viruses) (p < 0.001). B, risk of murine infection between inﬂuenza viruses bearing the surface glycoproteins shown (4 H7N3, 3 H7N7, 7 H7N9, 6 H5N1, 2 H3N2, 8
H1N1 viruses), statistical information provided in Table 2. C, risk of murine infection between North American lineage (9 viruses; n=61 inoculated mice) or Eurasian lineage (9 viruses;
n=84 inoculated mice) H7N3, H7N7, and H7N9 viruses (p > 0.01). D, risk of murine infectivity between H7 HPAI (6 viruses; n=84 inoculated mice) or LPAI (12 viruses; n=92
inoculated mice) inﬂuenza viruses listed in Table 1 (p > 0.01).

was associated with a higher risk of infection for both H7 and non-H7
viruses (p < 0.002 for both, Fig. 2A and B). This association was
maintained when H7 subtype viruses were separated into H7N9-only
and non-H7N9 groups, indicating that the association between 627K
and increased risk of infection was not confounded by the presence of
several 627K-bearing-bearing H7N9 viruses in our analysis (data not
shown). Interestingly, this analysis revealed that while both 627K and
627E H7 subtype viruses were associated with murine infection
following ocular inoculation, only non-H7 subtype viruses possessing
a lysine at position 627 were associated with murine infection (Fig. 2B).
This suggests that the residue at position 627 may have a greater
inﬂuence on the ability of non-H7 viruses to infect via the ocular route
compared to H7 viruses. However, logistic regression did not ﬁnd the
interaction between having an H7 HA and PB2 627K signiﬁcant, likely
due to the low power of this analysis.

Table 3
Ocular infectivity of reassortant influenza viruses in mice.
Day 3
Donor virus

a

A/Puerto Rico/8/1934
A/Vietnam/1203/2004b
A/Indonesia/5/2005b
A/Mexico/7218/2012
A/Anhui/1/2013
A/Shanghai/2/2013

Subtype
H1N1
H5N1
H5N1
H7N3
H7N9
H7N9

eye
c

0/5
0/3
0/3
0/5
3/5
4/4

Day 6
nose

lung

eye

nose

lung

0/5
0/3
0/3
0/5
0/5
1/4

0/5
0/3
0/3
0/5
0/5
0/4

0/5
0/3
0/3
0/5
5/5
4/4

0/5
0/3
0/3
0/5
5/5
3/4

0/5
0/3
0/3
0/5
2/5
0/4

a
Reassortant viruses possessing the HA and NA of the strain indicated and internal
genes from A/PR/8/34 virus.
b
The HA was modiﬁed by removal of the multibasic amino acid cleavage site.
c
Number of mice infected/total number of mice inoculated with 106 PFU or EID50/
5 µl virus by the ocular route.

3.4. Subtype-speciﬁc tropism following ocular inoculation
The amino acid position at 627 in PB2 has been identiﬁed as a
molecular determinant of host range and virulence for inﬂuenza
viruses, including H7 subtype viruses (Munster et al., 2007;
Subbarao et al., 1993). Many H5N1 and H7N9 inﬂuenza viruses
associated with human infection contain an E627K mutation in PB2
and possess enhanced virulence in small mammalian models (mouse
and ferret), in contrast with many ocular-tropic H7 subtype viruses
associated with human infection, which generally retain a glutamic acid
at position 627 (Fouchier et al., 2004). To examine the role of this
amino acid in murine ocular infectivity, we compared the risk of
infection following ocular inoculation between viruses with a lysine and
those with a glutamic acid residue at this position (Fig. 2). Among all
viruses identiﬁed in Table 1, 627K was associated with a signiﬁcantly
higher risk of infection in mice compared with 627E (64% vs 37%
respectively, p < 0.001). When viruses were separated by subtype, 627K

Due in part to replication-independent drainage of virus from the
eye to nasopharyngeal space, inﬂuenza virus can be detected in both
ocular and respiratory tract tissues following ocular inoculation (Belser
et al., 2012a). After ﬁnding that H7 subtype viruses are statistically
more likely to cause infection in mice following ocular inoculation
compared with H5 viruses, we next investigated more speciﬁcally the
frequency in which infectious virus is detected in the eye, nose, and
lung of mice inoculated by the ocular route with ocular-tropic (H7
subtype) or respiratory-tropic (H5 subtype) inﬂuenza viruses. Among
mice that were infected following ocular inoculation with either wildtype H5 or H7 subtype viruses, we found that H7 subtype viruses were
signiﬁcantly more likely to be detected in the eye or nose through day 6
p.i. than were H5 subtype viruses (p < 0.001 and p < 0.01, respectively),
with > 70% of H7 virus-infected mice possessing detectable virus in
16
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higher rate following ocular inoculation than other virus subtypes, but
also indicate that they are more likely to replicate in ocular tissue
during the acute phase of infection.
4. Discussion
H7 subtype inﬂuenza viruses typically exhibit an ocular tropism in
humans, causing conjunctivitis with or without associated respiratory
involvement. In this regard, inﬂuenza virus is similar to other principal
respiratory viruses (such as respiratory syncytial virus and adenovirus),
for which a particular subtype or subgroup appears to possess a nonrespiratory tropism. There is a poor understanding of what contributes
to the non-respiratory tropism of all of these viruses (Belser et al.,
2013c). Well-characterized laboratory models which recapitulate a
tropism detected in humans represent an essential tool to elucidate
the viral and host factors which confer this property. Our study
identiﬁes murine ocular inoculation as the only mammalian model
characterized to date which mirrors the apparent ocular tropism
associated with H7 virus subtype infection in humans.
Murine models for ocular inoculation and ocular infection have
been characterized for several respiratory pathogens (Belser et al.,
2013c). Despite the utility of these models to study ocular exposure to
virus, these species do not fully emulate the ocular disease observed in
humans. In particular, while conjunctivitis is the most frequently
reported ocular complication associated with inﬂuenza virus infection,
neither mice nor ferrets typically display macroscopic signs of conjunctivitis. While the lack of clinical presentation of ocular symptoms
limits our full capacity to study the ocular tropism of selected
respiratory viruses, these models nonetheless provide the ability to
better understand the capacity and propensity for ocular infection and
ocular replication.
Epithelia of the human cornea and surrounding conjunctiva bear a
predominance of α2-3 linked sialic acids (the cellular receptor preferred by most avian inﬂuenza viruses), and a paucity of α2-6 linked
sialic acids (preferred by most human inﬂuenza viruses) (Kumlin et al.,
2008). Thus, it has been postulated that avian inﬂuenza viruses may be
better suited to infecting the α2-3-rich ocular environment (Olofsson
et al., 2005). However, we showed previously via virus immunohistochemistry that both human and avian inﬂuenza viruses can attach to
murine corneal tissue, and further demonstrated productive virus
replication of both H5 and H7 inﬂuenza viruses in excised murine
whole corneas or corneal epithelial sheets (Belser et al., 2009b).
Furthermore, many H5N1 viruses tested that exhibit strong binding
to α2-3 sialosides were not capable of causing robust infection
following ocular inoculation in mice (including A/Hong Kong/486/
1997 and A/Indonesia/5/2005) (Belser et al., 2009b; Stevens et al.,
2008), whereas H7 subtype viruses with both strict α2-3 (including A/
Netherlands/219/2003) and mixed α2-3/α2-6 (including A/Canada/
504/2004) binding properties demonstrated a high capacity for
infectivity following ocular exposure (Belser et al., 2008). While
receptor-binding diﬀerences may yet contribute to ocular infectivity,
these data suggest that an α2-3 binding preference alone is insuﬃcient
to confer an ocular tropism to a virus which otherwise does not possess
this capacity. Further detailed characterization of the human ocular
surface, especially with regard to sialoside composition and density, is
needed, as is a greater understanding of conjunctivitis and/or other
ocular complications following human exposure to avian compared
with human inﬂuenza viruses.
We found that among H7N3, H7N7, and H7N9 viruses, murine
infectivity following ocular inoculation was independent of neuraminidase pairing or virus lineage. However, it is important to note that in
these two speciﬁc analyses, H7N2 and H7N8 pairings were excluded
due to low representation (n=2 unique viruses for each) and diversity
in our dataset. It is unclear if the lack of infectivity detected among
these viruses (North American avian isolates from 2002-3 [H7N2] or
2016 [H7N8]) following ocular inoculation in mice is truly representa-

Fig. 2. Contribution of PB2 627 to risk of murine infection following ocular inoculation
with inﬂuenza virus. Mice were inoculated by the ocular route with inﬂuenza viruses
shown in Table 1 and separated into “infected” or “not infected” groups based on
detection of infectious virus in the eye, nose, or lung through day 6 p.i. (limit of virus
detection, 100.8 EID50/ml or 10 PFU/ml). Error bars represent 99% conﬁdence intervals.
Relative risk of murine infection between inﬂuenza viruses bearing a lysine (K) or
glutamic acid (E) at position 627 among A, all H7 viruses (6 627K viruses, n=60
inoculated mice; 12 627E viruses, n=116 inoculated mice) or B, non-H7 viruses (9 627K
viruses, n=70 inoculated mice; 7 627E viruses, n=46 inoculated mice), p < 0.002 for both
comparisons.

Fig. 3. Diﬀerential detection of infectious virus following ocular inoculation in mice.
Mice were inoculated by the ocular route with H5 and H7 subtype inﬂuenza viruses
shown in Table 1. The risk of positive virus detection in the eye, nose, or lung through day
6 p.i. based on virus subtype is shown (limit of virus detection, 100.8 EID50/ml or 10
PFU/ml). Error bars represent 99% conﬁdence intervals. H5: 6 viruses, n=23 inoculated
mice per tissue. H7: 18 viruses, n=114 (eye) or 116 (nose, lung) inoculated mice.
Statistical signiﬁcance between H7 and H5 subtype viruses is p < 0.001 (eye), p < 0.01
(nose), p > 0.01 (lung).

both tissues (75% and 72%, respectively) (Fig. 3). In contrast, mice
infected with H5 viruses more frequently possessed detectable virus in
the nose (61%) than eye (26%), mirroring the respiratory tropism of
this subtype in humans. Rates of virus detection in the lung were not
signiﬁcantly diﬀerent between these virus subtypes (41% and 35% for
H7 and H5 subtype viruses, respectively). Viral titers detected in these
samples were generally low ( < 3 log10 PFU or EID50/ml) independent
of virus subtype (data not shown), suggesting that this murine model of
ocular inoculation is most suitable for examining frequency of detection of infectious virus, rather than the magnitude of the detected titer.
These analyses reveal that H7 subtype viruses not only infect mice at a
17
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system can fully recapitulate the diversity of the human ocular milieu,
the study of complex virus-host interactions at the ocular surface poses
an ongoing challenge in the laboratory. The murine model of ocular
inoculation described here currently represents the most stringent in
vivo model available to study the ocular tropism possessed by H7
subtype viruses. The use of models such as this has permitted the
investigation of antiviral drugs to mitigate viral replication and spread
following H7 ocular exposure (Belser et al., 2012b), underscoring the
need for well-characterized mammalian models to examine the diversity of inﬂuenza virus exposure routes and disease presentations.

tive of these HA-NA combinations or rather a reﬂection of poor
diversity in available viruses to include for this analysis and lack of
Eurasian lineage viruses to include for comparison. It should be noted
that Eurasian lineage, but not North American lineage H7N2 viruses,
have been associated with ocular disease in humans (Belser et al.,
2009a). Further investigation of these viruses, as well as other H7 HANA pairings causing poultry outbreaks (such as H7N1) will permit a
greater understanding of the propensity for ocular disease.
H7 subtype inﬂuenza viruses associated with ocular disease in
humans represent a wide range of heterogeneity, including variance
within the neuraminidase subtype, virus lineage, and pathotype.
Notably, H7 viruses associated with human conjunctivitis have acquired a HPAI phenotype by the traditional insertion of multiple basic
amino acids at the HA cleavage site, or by nonhomologous recombination with other viral gene segments or host ribosomal RNA (Hirst et al.,
2004; Lopez-Martinez et al., 2013; Pasick et al., 2005), underscoring a
diversity of cleavage site compositions. However, H7 LPAI viruses
bearing a single basic amino acid at the HA cleavage site have also been
associated with ocular disease in humans and murine ocular infection
(Belser et al., 2009a). To further support that ocular tropism is not
aﬀected by cleavage site, we found that H7N9-PR8 reassortant viruses,
but not H5N1-PR8 reassortant viruses, for which the multibasic amino
acid cleavage site was removed to match the single arginine cleavage
site composition of H7N9 viruses, were infectious following ocular
inoculation in mice (Table 3). Collectively, this study conﬁrms that
intrinsic properties of the H7 hemagglutinin, independent of cleavage
site, confer an enhanced ability to infect following ocular exposure in
mammals.
Compared with other H7 viruses, H7N9 inﬂuenza viruses associated with human infection more closely resemble H5N1 viruses with
regard to their respiratory tropism, elicitation of innate host responses,
and capacity to cause severe respiratory disease in humans (Chan et al.,
2013; Zeng et al., 2015). Despite an absence of ocular tropism with this
virus subtype, H7N9 viruses from 2013 to 2015 nonetheless appear to
possess the capacity for murine infectivity following ocular inoculation
(Fig. 1), and have been detected in ocular secretions from intranasally
inoculated mice (Bao et al., 2014). It is currently unclear what governs
this altered tissue tropism of H7N9 viruses in humans. Previous study
has identiﬁed a synergistic role for both HA and NA genes from a 2009
H1N1 virus in conferring conjunctival tropism in vitro (Chan et al.,
2011), identifying a need to further study in additional laboratory
models the role N9 neuraminidase may have in inﬂuencing this
property.
The role of internal genes in the ocular tropism of H7 inﬂuenza
viruses is not clear, and represents an area of much-needed research.
Our ﬁnding that the surface glycoproteins are not suﬃcient to maintain
the infectivity of an H7N3 HPAI virus by the ocular route (Table 3)
identiﬁes a potential role for internal proteins in this property,
warranting further study to identify the speciﬁc gene(s) responsible
for this result. It is possible that the replication advantage among
H7N9 and H5N1 viruses bearing E627K in PB2, demonstrated in both
avian and mammalian cells (Yamayoshi et al., 2015; Zhang et al.,
2014), permits enhanced infectivity by the ocular route in mice. H7N7
and H5N1 viruses bearing the 627K substitution have replicated to
higher titer than 627E-bearing viruses in human corneal and conjunctival cells in vitro (Belser et al., 2011b). However, studies
identifying that an E627K mutation alone do not uniformly confer
higher growth rates and virulence in mammalian models, and our
ﬁnding that H7 subtype viruses bearing either 627E and 627K can
infect mice following ocular inoculation (Fig. 2), suggests that this
substitution alone is neither necessary nor suﬃcient (Zhu et al., 2010).
Clearly, there remains a need for a better understanding of molecular
determinants of non-respiratory tropism of inﬂuenza virus.
The human eye is a complex organ, with several tissue components
exposed to the environment and thus susceptible to exposure to virus
infection by aerosol or fomites. As no one mammalian model or in vitro

Acknowledgements
The authors thank members of the international scientiﬁc community and the WHO Global Inﬂuenza Surveillance and Response System
(GISRS) for facilitating access to many of the viruses used in this study.
HMC is supported by the Oak Ridge Institute for Science and
Education. The ﬁndings and conclusions are those of the authors and
do not necessarily reﬂect the views of the funding agency.
References
Aamir, U.B., Naeem, K., Ahmed, Z., Obert, C.A., Franks, J., Krauss, S., Seiler, P.,
Webster, R.G., 2009. Zoonotic potential of highly pathogenic avian H7N3 inﬂuenza
viruses from Pakistan. Virology 390, 212–220.
Agresti, A., Liu, I.M., 1999. Modeling a categorical variable allowing arbitrarily many
category choices. Biometrics 55, 936–943.
Bao, L., Xu, L., Zhu, H., Deng, W., Chen, T., Lv, Q., Li, F., Yuan, J., Xu, Y., Huang, L., Li,
Y., Liu, J., Yao, Y., Yu, P., Chen, H., Qin, C., 2014. Transmission of H7N9 inﬂuenza
virus in mice by diﬀerent infective routes. Virol. J. 11, 185.
Belser, J.A., Blixt, O., Chen, L.M., Pappas, C., Maines, T.R., Van Hoeven, N., Donis, R.,
Busch, J., McBride, R., Paulson, J.C., Katz, J.M., Tumpey, T.M., 2008. Contemporary
North American inﬂuenza H7 viruses possess human receptor speciﬁcity:
implications for virus transmissibility. Proc. Natl. Acad. Sci. USA 105, 7558–7563.
Belser, J.A., Bridges, C.B., Katz, J.M., Tumpey, T.M., 2009a. Past, present, and possible
future human infection with inﬂuenza virus A subtype H7. Emerg. Infect. Dis. 15,
859–865.
Belser, J.A., Creager, H.M., Sun, X., Gustin, K.M., Jones, T., Shieh, W.J., Maines, T.R.,
Tumpey, T.M., 2016. Mammalian pathogenesis and transmission of H7N9 inﬂuenza
viruses from three waves, 2013–2015. J. Virol. 90, 4647–4657.
Belser, J.A., Davis, C.T., Balish, A., Edwards, L.E., Zeng, H., Maines, T.R., Gustin, K.M.,
Martinez, I.L., Fasce, R., Cox, N.J., Katz, J.M., Tumpey, T.M., 2013a. Pathogenesis,
transmissibility, and ocular tropism of a highly pathogenic avian inﬂuenza A (H7N3)
virus associated with human conjunctivitis. J. Virol. 87, 5746–5754.
Belser, J.A., Gustin, K.M., Katz, J.M., Maines, T.R., Tumpey, T.M., 2014. Inﬂuenza virus
infectivity and virulence following ocular-only aerosol inoculation of ferrets. J. Virol.
88, 9647–9654.
Belser, J.A., Gustin, K.M., Maines, T.R., Pantin-Jackwood, M.J., Katz, J.M., Tumpey,
T.M., 2012a. Inﬂuenza virus respiratory infection and transmission following ocular
inoculation in ferrets. PLoS Pathog. 8, e1002569.
Belser, J.A., Gustin, K.M., Pearce, M.B., Maines, T.R., Zeng, H., Pappas, C., Sun, X.,
Carney, P.J., Villanueva, J.M., Stevens, J., Katz, J.M., Tumpey, T.M., 2013b.
Pathogenesis and transmission of avian inﬂuenza A (H7N9) virus in ferrets and mice.
Nature 501, 556–559.
Belser, J.A., Jayaraman, A., Raman, R., Pappas, C., Zeng, H., Cox, N.J., Katz, J.M.,
Sasisekharan, R., Tumpey, T.M., 2011a. Eﬀect of D222G mutation in the
hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the
2009 pandemic H1N1 inﬂuenza virus. PLoS One 6, e25091.
Belser, J.A., Rota, P.A., Tumpey, T.M., 2013c. Ocular tropism of respiratory viruses.
Microbiol. Mol. Biol. Rev. 77, 144–156.
Belser, J.A., Sleeman, K., Pearce, M.B., Katz, J.M., Gubareva, L.V., Tumpey, T.M., 2012b.
Oseltamivir inhibits H7 inﬂuenza virus replication in mice inoculated by the ocular
route. Antimicrob. Agents Chemother. 56, 1616–1618.
Belser, J.A., Wadford, D.A., Pappas, C., Gustin, K.M., Maines, T.R., Pearce, M.B., Zeng,
H., Swayne, D.E., Pantin-Jackwood, M., Katz, J.M., Tumpey, T.M., 2010.
Pathogenesis of pandemic inﬂuenza A (H1N1) and triple-reassortant swine inﬂuenza
A (H1) viruses in mice. J. Virol. 84, 4194–4203.
Belser, J.A., Wadford, D.A., Xu, J., Katz, J.M., Tumpey, T.M., 2009b. Ocular infection of
mice with inﬂuenza A (H7) viruses: a site of primary replication and spread to the
respiratory tract. J. Virol. 83, 7075–7084.
Belser, J.A., Zeng, H., Katz, J.M., Tumpey, T.M., 2011b. Ocular tropism of inﬂuenza A
viruses: identiﬁcation of H7 subtype-speciﬁc host responses in human respiratory
and ocular cells. J. Virol. 85, 10117–10125.
Chan, M.C., Chan, R.W., Chan, L.L., Mok, C.K., Hui, K.P., Fong, J.H., Tao, K.P., Poon,
L.L., Nicholls, J.M., Guan, Y., Peiris, J.S., 2013. Tropism and innate host responses
of a novel avian inﬂuenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures
of the human respiratory tract. Lancet Respir. Med. 1, 534–542.
Chan, M.C., Chan, R.W., Yu, W.C., Ho, C.C., Yuen, K.M., Fong, J.H., Tang, L.L., Lai,
W.W., Lo, A.C., Chui, W.H., Sihoe, A.D., Kwong, D.L., Wong, D.S., Tsao, G.S., Poon,

18

Virology 502 (2017) 13–19

J.A. Belser et al.

the haemagglutinin and matrix genes was responsible for the emergence of a highly
pathogenic H7N3 avian inﬂuenza virus in British Columbia. J. Gen. Virol. 86,
727–731.
Reed, L.J., Muench, H.A., 1938. A simple method of estimating ﬁfty per cent endpoints.
Am. J. Hyg. 27, 493–497.
Ridenour, C., Johnson, A., Winne, E., Hossain, J., Mateu-Petit, G., Balish, A., Santana,
W., Kim, T., Davis, C., Cox, N.J., Barr, J.R., Donis, R.O., Villanueva, J., Williams,
T.L., Chen, L.M., 2015. Development of inﬂuenza A(H7N9) candidate vaccine viruses
with improved hemagglutinin antigen yield in eggs. Inﬂuenza Other Respir. Virus. 9,
263–270.
Stevens, J., Blixt, O., Chen, L.M., Donis, R.O., Paulson, J.C., Wilson, I.A., 2008. Recent
avian H5N1 viruses exhibit increased propensity for acquiring human receptor
speciﬁcity. J. Mol. Biol. 381, 1382–1394.
Subbarao, E.K., London, W., Murphy, B.R., 1993. A single amino acid in the PB2 gene of
inﬂuenza A virus is a determinant of host range. J. Virol. 67, 1761–1764.
Sun, R., Luo, J., Gao, Y., He, H., 2009. Diﬀerent infection routes of avian inﬂuenza A
(H5N1) virus mice. Integr. Zool. 4, 402–408.
Sun, X., Belser, J.A., Pulit-Penaloza, J.A., Zeng, H., Lewis, A., Shieh, W.J., Tumpey, T.M.,
Maines, T.R., 2016a. Pathogenesis and transmission assessments of two H7N8
inﬂuenza viruses recently isolated from turkey farms in Indiana using mouse and
ferret models. J. Virol..
Sun, X., Belser, J.A., Tumpey, T.M., 2016b. A novel eight amino acid insertion
contributes to the hemagglutinin cleavability and the virulence of a highly pathogenic
avian inﬂuenza A (H7N3) virus in mice. Virology 488, 120–128.
Tannock, G.A., Paul, J.A., Barry, R.D., 1985. Immunization against inﬂuenza by the
ocular route. Vaccine 3, 277–280.
To, K.K., Chan, J.F., Yuen, K.Y, 2014. Viral lung infections: epidemiology, virology,
clinical features, and management of avian inﬂuenza A(H7N9). Curr. Opin. Pulm.
Med. 20, 225–232.
The R Core Team, 2015. R: a language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria.
World Health Organization Global Inﬂuenza Program Surveillance, N., 2005. Evolution
of H5N1 avian inﬂuenza viruses in Asia. Emerg Infect Dis 11, pp. 1515–1521.
Yamayoshi, S., Fukuyama, S., Yamada, S., Zhao, D., Murakami, S., Uraki, R., Watanabe,
T., Tomita, Y., Neumann, G., Kawaoka, Y., 2015. Amino acids substitutions in the
PB2 protein of H7N9 inﬂuenza A viruses are important for virulence in mammalian
hosts. Sci. Rep. 5, 8039.
Zeng, H., Belser, J.A., Goldsmith, C.S., Gustin, K.M., Veguilla, V., Katz, J.M., Tumpey,
T.M., 2015. A(H7N9) virus results in early induction of proinﬂammatory cytokine
responses in both human lung epithelial and endothelial cells and shows increased
human adaptation compared with avian H5N1 virus. J. Virol. 89, 4655–4667.
Zeng, H., Goldsmith, C., Thawatsupha, P., Chittaganpitch, M., Waicharoen, S., Zaki, S.,
Tumpey, T.M., Katz, J.M., 2007. Highly pathogenic avian inﬂuenza H5N1 viruses
elicit an attenuated type i interferon response in polarized human bronchial
epithelial cells. J. Virol. 81, 12439–12449.
Zhang, H., Li, X., Guo, J., Li, L., Chang, C., Li, Y., Bian, C., Xu, K., Chen, H., Sun, B.,
2014. The PB2 E627K mutation contributes to the high polymerase activity and
enhanced replication of H7N9 inﬂuenza virus. J. Gen. Virol. 95, 779–786.
Zhu, H., Wang, J., Wang, P., Song, W., Zheng, Z., Chen, R., Guo, K., Zhang, T., Peiris,
J.S., Chen, H., Guan, Y., 2010. Substitution of lysine at 627 position in PB2 protein
does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology 401,
1–5.

L.L., Guan, Y., Nicholls, J.M., Peiris, J.S., 2010. Tropism and innate host responses
of the 2009 pandemic H1N1 inﬂuenza virus in ex vivo and in vitro cultures of human
conjunctiva and respiratory tract. Am. J. Pathol. 176, 1828–1840.
Chan, R.W., Kang, S.S., Yen, H.L., Li, A.C., Tang, L.L., Yu, W.C., Yuen, K.M., Chan, I.W.,
Wong, D.D., Lai, W.W., Kwong, D.L., Sihoe, A.D., Poon, L.L., Guan, Y., Nicholls,
J.M., Peiris, J.S., Chan, M.C., 2011. Tissue tropism of swine inﬂuenza viruses and
reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J.
Virol. 85, 11581–11587.
Chosewood, L.C., Wilson, D.E., Centers for Disease Control and Prevention (U.S.),
National Institutes of Health (U.S.), 2009. Biosafety in microbiological and
biomedical laboratories, 5th ed. U.S. Dept. of Health and Human Services, Public
Health Service, Centers for Disease Control and Prevention, National Institutes of
Health, Washington, D.C
Dorai-Raj, S., 2014. Binom: Binomial Conﬁdence Intervals for Several Parameterizations.
Fouchier, R.A., Schneeberger, P.M., Rozendaal, F.W., Broekman, J.M., Kemink, S.A.,
Munster, V., Kuiken, T., Rimmelzwaan, G.F., Schutten, M., Van Doornum, G.J.,
Koch, G., Bosman, A., Koopmans, M., Osterhaus, A.D., 2004. Avian inﬂuenza A virus
(H7N7) associated with human conjunctivitis and a fatal case of acute respiratory
distress syndrome. Proc. Natl. Acad. Sci. USA 101, 1356–1361.
Hirst, M., Astell, C.R., Griﬃth, M., Coughlin, S.M., Moksa, M., Zeng, T., Smailus, D.E.,
Holt, R.A., Jones, S., Marra, M.A., Petric, M., Krajden, M., Lawrence, D., Mak, A.,
Chow, R., Skowronski, D.M., Tweed, S.A., Goh, S., Brunham, R.C., Robinson, J.,
Bowes, V., Sojonky, K., Byrne, S.K., Li, Y., Kobasa, D., Booth, T., Paetzel, M., 2004.
Novel avian inﬂuenza H7N3 strain outbreak, British Columbia. Emerg. Infect. Dis.
10, 2192–2195.
Koziol, N., Bilder, C., 2014. MRCV: methods for analyzing multiple response categorical
variables. MRCVs.
Kumlin, U., Olofsson, S., Dimock, K., Arnberg, N., 2008. Sialic acid tissue distribution
and inﬂuenza virus tropism. Inﬂuenza Other Respir. Virus 2, 147–154.
Lopez-Martinez, I., Balish, A., Barrera-Badillo, G., Jones, J., Nunez-Garcia, T.E., Jang, Y.,
Aparicio-Antonio, R., Azziz-Baumgartner, E., Belser, J.A., Ramirez-Gonzalez, J.E.,
Pedersen, J.C., Ortiz-Alcantara, J., Gonzalez-Duran, E., Shu, B., Emery, S.L., Poh,
M.K., Reyes-Teran, G., Vazquez-Perez, J.A., Avila-Rios, S., Uyeki, T., Lindstrom, S.,
Villanueva, J., Tokars, J., Ruiz-Matus, C., Gonzalez-Roldan, J.F., Schmitt, B.,
Klimov, A., Cox, N., Kuri-Morales, P., Davis, C.T., Diaz-Quinonez, J.A., 2013. Highly
pathogenic avian inﬂuenza A(H7N3) virus in poultry workers, Mexico, 2012. Emerg.
Infect. Dis. 19, 1531–1534.
Michaelis, M., Geiler, J., Klassert, D., Doerr, H.W., Cinatl, J., Jr., 2009. Infection of
human retinal pigment epithelial cells with inﬂuenza A viruses. Investig.
Ophthalmol. Vis. Sci. 50, 5419–5425.
Munster, V.J., de Wit, E., van Riel, D., Beyer, W.E., Rimmelzwaan, G.F., Osterhaus, A.D.,
Kuiken, T., Fouchier, R.A., 2007. The molecular basis of the pathogenicity of the
Dutch highly pathogenic human inﬂuenza A H7N7 viruses. J. Infect. Dis. 196,
258–265.
O'Neill, E., Donis, R.O., 2009. Generation and characterization of candidate vaccine viruses
for prepandemic inﬂuenza vaccines. Curr. Top. Microbiol. Immunol. 333, 83–108.
OIE, 2015. Avian Inﬂuenza (Infection with avian inﬂuenza viruses). Chapter 2. 3.4.
〈http://www.oie.int/ﬁleadmin/Home/eng/Health_standards/tahm/2.03.04_AI.
pdf〉
Olofsson, S., Kumlin, U., Dimock, K., Arnberg, N., 2005. Avian inﬂuenza and sialic acid
receptors: more than meets the eye? Lancet Infect. Dis. 5, 184–188.
Pasick, J., Handel, K., Robinson, J., Copps, J., Ridd, D., Hills, K., Kehler, H., Cottam-Birt,
C., Neufeld, J., Berhane, Y., Czub, S., 2005. Intersegmental recombination between

19

